Delivery Order SPE2DB22D3501-SPE2DB25FVT93

Award Date 5/22/25
Potential Completion Date 5/23/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the procurement of Phenobarbital 130 mg/ml vials. The contract is a firm-fixed-price delivery order with a ceiling value of $6,273.13 and a period of performance through March 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568161338 - Phenobarbital 65 mg/ml vial. The $3,905.64 firm fixed-price contract has a completion date of May 7, 2025. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide 65 mg/ml vials of the drug Phenobarbital. The $1,008.66 fixed-price contract has a completion date of February 13, 2025. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the company to supply a wide range of pharmaceutical products and medical supplies to support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,490.14 and is a Delivery Order with a Firm Fixed Price pricing type. The contract is for the supply of 4567850091 - PHENOBARBITAL 130 MG/ML VIALML. This appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Phenobarbital 130 mg/ml vials, a medication used for various medical conditions. The contract has a firm fixed price of $5,283.68 and a performance period ending on May 12, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Phenobarbital 130 mg/mL vials. The order has a ceiling value of $1,244.41 and is a firm fixed-price contract with a performance period ending on July 30, 2024. This order is not associated with a set-aside program. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies,...
This is a firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $1,058.50, is for the delivery of 4564074211 - PHENOBARBITAL 130 MG/ML VIALML. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), to provide pharmaceutical products and medical supplies in support of military treatment...
This federal contract award is a $2,339.82 Firm Fixed Price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 130 mg/ml vials of Phenobarbital, a medication commonly used to treat seizures and certain types of brain disorders. This contract is not set-aside and is awarded as an open competition. Amerisourcebergen Drug Corp holds a substantial...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,404.08 firm fixed-price contract is for the delivery of Phenobarbital 130 mg/ml vials. The contract has an ultimate completion date of June 10, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of 130 mg/mL vials of the drug Phenobarbital. The contract has a ceiling value of $3,785.92 and is a Delivery Order (DO) under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVT93
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 65 mg/ml PHENOBARBITAL vials. The contract is a firm fixed-price delivery order with a ceiling value of $1,293.27 and a period of performance ending on May 23, 2025. The award is not designated as a set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.

Generated 8/21/25, 10:00 AM